Catalyst Wire Dossier Catalyst Wire Dossier

polyvalent immunoglobulin

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for polyvalent immunoglobulin, covering 2021-08-19 to 2021-08-19. Get the full timeline:

Most recent: Clinical Trial Update: Polyvalent Immunoglobulin in COVID-19 Related ARds [Phase 3]

See pricing